Quest Diagnostics Inc vs Samsara Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Samsara Inc trades at $40.08 (market cap $23.49B). The key difference: Quest Diagnostics Inc and Samsara Inc are close in size by market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Samsara Inc pays none. Which is the better fit depends on your goals.
| DGX | IOT | |
|---|---|---|
Market Cap | $26.21B | $23.49B |
Sector | Health | Technology |
52-Week High | $238.50 | $45.22 |
52-Week Low | $173.49 | $24.25 |
Enterprise Value | $31.97B | $22.76B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →